Doxycycline Hyclate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

34 API Suppliers, 17 USDMF, 9 CEP/COS, 1 JDMF, 2 EU WC, 2 KDMF, 17 NDC API, 19 Listed Suppliers

DEVELOPMENTS

23 Drug(s) in Development

23 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Formulations

208 Dossiers, 175 FDA Orange Book, 2 Europe, 12 Canada, 19 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 150MG BASE, TABLET;ORAL - EQ 75MG BASE, TABLET;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED RELEASE;ORAL - EQ 100MG BASE, CAPSULE, DELAYED RELEASE;ORAL - EQ 75MG BASE, SYSTEM, EXTENDED RELEASE;PERIODONTAL - 50MG, TABLET, DELAYED RELEASE;ORAL - EQ 100MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 120MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 150MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 200MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 50MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 60MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 75MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 80MG BASE

TABLET;ORAL - EQ 150MG BASE
TABLET;ORAL - EQ 75MG BASE
TABLET;ORAL - EQ 100MG BASE
CAPSULE;ORAL - EQ 100MG BASE
CAPSULE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, DELAYED RELEASE;ORAL - EQ 100MG BASE
CAPSULE, DELAYED RELEASE;ORAL - EQ 75MG BASE
SYSTEM, EXTENDED RELEASE;PERIODONTAL - 50MG
TABLET, DELAYED RELEASE;ORAL - EQ 100MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 120MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 150MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 200MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 50MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 60MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 75MG BASE
TABLET, DELAYED RELEASE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 40 Kerry, 33 BASF, 29 Roquette, 22 Microlex e.U, 17 SPI Pharma, 14 Seppic, 12 Gangwal Healthcare, 12 Actylis, 12 Sigachi Industries, 12 Gangwal Chemicals, 11 Corel Pharma Chem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Ideal Cures Pvt Ltd, 7 Boai NKY Pharmaceuticals Ltd, 7 DFE Pharma, 7 Nanjing Well Pharmaceutical, 6 Lonza Capsugel, 5 Kima Chemical, 5 Ingredion Pharma Solutions, 4 ACG Worldwide, 4 The Dow Chemical Company, 4 Pharmatrans-Sanaq, 4 DKSH, 4 Prachin Chemical, 4 Vasa Pharmachem, 3 Rochem International Inc, 3 Finar, 3 Ulanqab Kema New Material, 2 Nomisma Healthcare, 2 Qualicaps, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Aeon Procare, 2 Seqens, 2 Pfanstiehl, 2 Jai Radhe Sales, 1 Zhejiang Huakang Pharmaceutical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Clariant, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Vertellus, 1 Nanjing Bold Chemical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 46 Direct Compression, 44 Disintegrants & Superdisintegrants, 36 Controlled & Modified Release, 32 Granulation, 32 Thickeners and Stabilizers, 29 Solubilizers, 26 Parenteral, 26 Film Formers & Plasticizers, 25 Taste Masking, 21 Lubricants & Glidants, 18 Chewable & Orodispersible Aids, 17 Topical, 17 Co-Processed Excipients, 9 Empty Capsules, 8 API Stability Enhancers, 7 Rheology Modifiers, 6 Emulsifying Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin